Longevity Marketcap Newsletter
ArchiveTopDiscussionAbout
2021 Industry Review. NewLimit. New Funds. Longevity Biotech Job Fair.
CommentShare
Altos Labs. ODX. Impetus Grants. Healthspan Capital. Media is Code.
Comment1Share
Longevity Resources [updated Aug 13, 2021]Here’s a list of longevity science and industry resources to get you started. If you have any suggestions please leave them in the comments belo…
Comment4Share
On Deck Longevity Biotech. VitaDAO raise. Insilico Medicine, Continuum Biosciences, Vita Therapeutics. Mystery non-profit. Adventures in longevity.
Comment6Share
Aducanumab! VitaDAO token sale. Lineage Cell. Non-Traditional.
CommentShare
You don't need formal biology training to get involved in longevity. Here are some examples of leaders and founders working on aging that came from…
CommentShare
Oisin and Loyal seed rounds. HAYA stealth. How to start a longevity biotech company.
CommentShare
Seismic funding rumors. Unity passes Phase 1. Deciduous Tx. Apprentices and Whitepapers. Humans for Longevity.
CommentShare
Michael Greve's €300M commitment. Dyno / Stealth / FOXO. Thoughts on what the aging field needs.
CommentShare
Turn Bio funding. Unity Biotechnology and Denali Therapeutics updates. The Cost of Aging.
CommentShare
Rejuvenate Bio. Selphagy and autophagy. Is aging a disease?
CommentShare
Samumed shakeup and IPO. LongevityBase.org. 12 Seconds to Mars.
CommentShare
© 2022 LongevityMarketcap.com. (9969985 Canada Ltd). See privacy, terms and information collection notice
Publish on Substack
Longevity Marketcap Newsletter is on Substack – the place for independent writing